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Abstract
The major facilitator superfamily (MFS) transporter Pho84 and the type III transporter Pho89 are responsible for metabolic
effects of inorganic phosphate in yeast. While the Pho89 ortholog Pit1 was also shown to be involved in phosphate-
activated MAPK in mammalian cells, it is currently unknown, whether orthologs of Pho84 have a role in phosphate-sensing
in metazoan species. We show here that the activation of MAPK by phosphate observed in mammals is conserved in
Drosophila cells, and used this assay to characterize the roles of putative phosphate transporters. Surprisingly, while we
found that RNAi-mediated knockdown of the fly Pho89 ortholog dPit had little effect on the activation of MAPK in Drosophila
S2R+ cells by phosphate, two Pho84/SLC17A1–9 MFS orthologs (MFS10 and MFS13) specifically inhibited this response.
Further, using a Xenopus oocyte assay, we show that MSF13 mediates uptake of [
33P]-orthophosphate in a sodium-
dependent fashion. Consistent with a role in phosphate physiology, MSF13 is expressed highest in the Drosophila crop,
midgut, Malpighian tubule, and hindgut. Altogether, our findings provide the first evidence that Pho84 orthologs mediate
cellular effects of phosphate in metazoan cells. Finally, while phosphate is essential for Drosophila larval development, loss
of MFS13 activity is compatible with viability indicating redundancy at the levels of the transporters.
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Introduction
Inorganic phosphate, the mono- or divalent anion of
phosphoric acid [HPO4
32,H 2PO4
22], is required for cellular
functions such as DNA and membrane lipid synthesis, generation
of high-energy phosphate esters, and intracellular signaling [1].
Disturbances of phosphate homeostasis are serious human
disorders [2]: the clinical consequences of severe hypophospha-
temia, which for example is seen in severe malnutrition or tumor-
induced hypophosphatemia [3], include hemolysis, skeletal
muscle myopathy, cardiomyopathy, neuropathy, osteomalacia
and, in some cases contribute to death. Hyperphosphatemia on
the other hand leads to tissue calcifications and metabolic
changes, which are to date poorly understood. Hyperphospha-
temia is encountered most frequently in patients with chronic
kidney disease (CKD), which affects 20 Million Americans today,
and the serum phosphate level is an important predictor of
mortality in this population [4,5,6]. It is also seen in familial
hyperphosphatemic tumoral calcinosis, a human disorder that
was recently attributed to loss-of function mutations in the genes
encoding fibroblast growth factor 23 (FGF23), UDP-GalNAc
transferase 3 (GALNT3), and Klotho (KL)[ 7 ] .F u r t h e r m o r e ,
mouse models with hyperphosphatemia due to loss-of-function
mutations in Fgf23, Kl or Galnt3 die prematurely unless they are
placed on a phosphate-restricted diet to improve their lifespan
[8,9,10] and it is possible that similar mechanisms underlie the
known beneficial effects of dietary phosphate-restriction in
humans with CKD. An understanding of the molecular basis
underlying the metabolic and endocrine phosphate effects is
therefore of great significance for human disease.
The intracellular concentration of inorganic phosphate is
maintained by membrane transporters which accumulate phos-
phate against an electrochemical gradient coupled to the plasma
membrane H
+ [11] or Na
+ gradients [12], at concentrations larger
than would be predicted if phosphate were distributed passively
across the membrane. Much has been learned about phosphate
transport in bacteria and in yeast. Bacteria sense phosphate using a
four-component Pst-transporter (PstS, PstA, PstB, PstC), which is
similar to mammalian ABC transporters. Binding of phosphate to
PstSABC represses a two component signaling system composed of
the sensory histidine kinase PhoR and the winged helix transcrip-
tion factor PhoB [13,14]. Different from bacteria, the main
phosphate-sensing transporter Pho84 in yeast belongs to the major
facilitator family (MFS) which regulates the cyclin/cyclin-depen-
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Pho80–Pho85 in turn regulates the subcellular localization of the
basic helix-loop-helix transcription factor Pho4, which belongs to
the myc family. Interestingly, a number of transporters, Pho87, 89,
90 and 91, can compensate for loss of Pho84 under certain
conditions in yeast suggesting that signaling is independent of the
mode of cellular uptake, and that intracellular phosphate is the
signal for gene-regulation [16]. However, the fact that overex-
pression of a phosphate-transport deficient Pho84 variant can
rescue regulation of the extracellular alkaline phosphatase Pho5 by
phosphate in Pho84 deficient strains, while overexpression of
Pho87, Pho90, Pho91 or Pit is ineffective, suggests, that binding of
extracellular phosphate alone may be sufficient for some
downstream effects of phosphate [16].
Humans have three types of membrane-bound phosphate
transporters: The type I transporters SLC17A1–9 that belong to
the MFS group. MFS are widely expressed and some also mediate
transport of organic anions, such as uric or sialic acid, or certain
antibiotics [17,18]. Conversely, the human type II phosphate
transporters NPT2a, NPT2b, and NPT2c, and type III phosphate
transporters Pit1 and Pit2 are thought to be exclusively
transporting phosphate [12,19]. NPT2a, NPT2c, and Pit2 are
expressed in the renal proximal tubule and mediate re-absorption
of phosphate from the urine, NPT2b and Pit2 mediate absorption
of phosphate from the diet in the gut, and Pit1 is ubiquitously
expressed and facilitates uptake of phosphate from the circulation
to supply cellular functions [20,21]. Pho84 belongs to the MFS
group, Pho87, 90 and 91 are related to metazoan sodium-sulfate
transporters (SLC13A1–4), and Pho89 is related to the type III
sodium-phosphate transporters SLC20A1 (Pit-1) and SLC20A2 (Pit-
2) [22,23].
Compared to bacteria and yeast, little is known about the
metabolic effects of phosphate in metazoan species [20,21]. Over
the past decade, activation of MAPK by inorganic phosphate at
concentrations between 5–10 mM alone was demonstrated in
multiple cell lines including MC3T3 mouse fibroblast cells [24,25],
chondrogenic ATDC5 cells, MC3T3-E1 osteoblasts and ST2
murine bone marrow stromal cells [26], HEK293 human
proximal tubular cells [27], and lung alveolar cells [28]. Although
some cell lines, for example C2C12 or L929 cells, are less
responsive than others [26], activation of MAPK by phosphate
appears to be quite universal. Addition of phosphonoformic acid
(PFA), a competitive antagonist of phosphate transporters and
cellular phosphate uptake [29,30], or siRNA-mediated knockdown
of the type III transporter Pit1 blocks activation of MAPK by
phosphate in HEK293 cells [27]. Furthermore, using cell lines
expressing a Pi-transport-deficient Pit1 transporter, Beck et al.
recently reported that Pit1 may have transport-independent effects
on cell proliferation and tumor growth in vitro and in vivo, although
it remains to be shown whether these effects depend on phosphate-
binding to Pit1 [31]. Targeted deletion, hypomorphic and
overexpression mutants of Pit1 support a role of this transporter
in liver growth and phosphate homeostasis [32,33,34], however,
surprisingly, Pit1 null mice showed normal embryonic and fetal
development. Collectively, these data suggest an important role of
the type III transporter Pit1 in mammalian phosphate-sensing, but
it remains unclear whether phosphate is required to enter the cell
to activate an intracellular sensor, whether it binds extracellularly,
or whether multiple transporters are involved.
In multicellular organisms the circulating phosphate levels and
total body phosphate content are tightly regulated by a number of
hormones, including parathyroid hormone (PTH), 1,25-dihydroxy
vitamin D (1,25(OH)2D), and fibroblast growth factor 23 (FGF23).
Serum phosphate feeds back to regulate these factors in an
endocrine fashion [2] with high phosphate increasing the secretion
of PTH and FGF23 and low phosphate stimulating the synthesis of
1,25(OH)2D, the active form of vitamin D [21]. Owing to the lack
of suitable cell lines to permit the study of the synthesis and
secretion of these hormones in vitro, it is currently unknown
whether the MAPK pathway is involved in these endocrine effects
of phosphate. Thus, it remains unclear whether the ‘‘metabolic’’
and the ‘‘endocrine’’ effects of phosphate use the same or different
signal transduction cascades.
To understand whether phosphate-induced MAPK is evolu-
tionarily conserved, we investigated the response to phosphate in
Drosophila cells. We show that, as in mammalian cells, phosphate
activates MAPK in fly cells, and used this assay to identify
members of the MFS of transporters involved in sensing
phosphate. Our findings indicate that two type I sodium-
phosphate Pho84/SLC17A1–9 MFS orthologs (MFS10 and
MFS13) mediate some of the cellular effects of phosphate, a
finding which may be relevant to higher species and humans.
Materials and Methods
Cell culture
The Drosophila hemocyte cell lines S2R+, a variant adherent S2
line [35], and Kc167 cells [36] were cultured in Schneider’s
Drosophila medium (Invitrogen) supplemented with 10% heat-
inactivated fetal bovine serum (Hyclone, Fisher Scientific) and
penicillin/streptomycin at 25 C using a humidified incubator.
Routine culture was performed in Schneider’s medium
containing 7 mM sodium-phosphate buffer (pH 7.4). Cells were
sub-cultured with a cell scraper and plated at 200.000 cells/well in
48-well plates. After 48-hr. culture in phosphate-free Schneider’s
medium (Invitrogen) containing 10% FBS (final phosphate
concentration about 100 uM) in 48-multiwell plates, cells were
pretreated with phosphonoformic acid (PFA) 5–30 mM (Sigma),
Ly294002 50 uM (Sigma), or UO126 30 uM (Sigma) for 60 min.,
followed by stimulation with sodium phosphate buffer 1–10 mM
(pH7.4), 10 mM Na-sulfate (pH 7.4), or human insulin 25 ug/ml
(Sigma) for 1–30 min. The phosphate concentration in phosphate-
free medium was sufficient to permit survival of S2R+ cells,
although proliferation rate was somewhat slower, as indicated by
Trypan blue staining, and their responses to insulin and
phosphate.
Western blot analysis
Following pretreatment and stimulation the 48-well plate was
placed on ice and the culture medium was aspirated. Cells were
then lysed with 50 ul lysis buffer (62.5 mM Tris HCL (pH 6.8),
1% SDS, 1 mM EDTA, 1 mM EGTA, 0.05 TiU/ml aprotonin,
1 M PMSF, 100 mM Na-orthovanadate, 0.8% SDS, 3.2%
glycerol, 2% beta mercaptoethanol, 0.0015% bromephenolblue).
15 ul cell lysates were then separated on 12% Tris-HCl SDS-
polyacrylamide, electro-transferred to PVDF membranes and
hybridized with anti-phospho-ERK1/2 #9106 or #4730 or total-
ERK1/2 antibody #4695 (Cell signaling) in phosphate buffered
saline containing 0.1% Tween 20 (PBST) and 5% non-fat dry milk
at 4 C over night. On the following day, a developing reaction
with horseradish-peroxidase conjugated secondary antibodies in
PBST+5% non-fat dry milk was preformed at room temperature
for 60 min. to permit detection of the phospho- or total-ERK
signal using chemiluminscence/autoradiography (Perkin Elmer).
Following densitometric analysis of the autoradiograms, phospho/
total ERK ratios were converted into fold over basal to permit
statistical evaluation of pooled Western blot experiments.
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We downloaded protein sequences from Ensembl version 56
[37] and used BLAST to cluster all known yeast, Drosophila and
human proteins containing the MFS protein domain PF07690
[38] into five main families. Next using Bayesian phylogenetic
reconstruction (MrBayes v3.1.2 [39]) we identified 29 fly orthologs
that are most closely related to yeast Pho84 and human
SLC17A1–9, an anion transporter subfamily with members
known to mediate phosphate transport. Refer to Table S2 for all
blast hits S. cerevisiae vs. D. melanogaster (Table S2.1), D.
melanogaster vs. D. melanogaster (Table S2.2), D. melanogaster
vs. human (Table S2.3).
RNAi knockdown experiments
RNAi knockdown experiments were performed in S2R+ cells as
described previously [40]. We used the SnapDragon tool from the
Drosophila RNAi Screening Center [41,42] to design double
stranded RNAs (dsRNA) for RNA interference (RNAi) analysis
of the eight MFS type I transporters expressed in S2R+ cells
(Table 1).
dsRNA was synthesized from PCR templates using the T7
Megascript kit (Ambion). See Table S1 for the primer sequences
used. Following TAE-2% agarose gel electrophoresis and
densitometric quantification at 260 nm (Nano-drop 8000, Fisher
Scientific) for quality control, 200.000 S2R+ cells/well in 48-
multiwell plates were incubated with 3 ug dsRNA per well in
250 ul serum-, phosphate- and antibiotic-free medium supple-
mented with 10 mM HEPES (pH 7.4) for 45 min. at 25 C.
Transfection was stopped by the addition of 250 ul phosphate-free
medium containing 20% heat-inactivated FBS, 26 penicillin/
streptomycin and 10 mM HEPES (pH 7.4). After culture for three
days cells were challenged with 10 mM sodium-phosphate (pH7.4)
or 25 ug/ml Insulin for 3 min. Lysates were analyzed by Western
analysis as described above. For quantitative RT-PCR analysis,
lysates were prepared using 300 ul RLT-PLUS per well according
to the manufacturer’s instructions for RNeasy-micro PLUS kit
(Qiagen). Following reverse transcription using the Omni-script kit
(Qiagen), quantitative PCR using the Cybr Green kit (Qiagen) was
performed using intron-overlapping primers, which had been
chosen so to not overlap the dsRNA target sequences (see Table
S1 for primer sequences). To calculate efficiency of knockdown,
target mRNA expression corrected for the actin mRNA expression
of cells treated with target RNAi was compared to target mRNA
expression corrected for actin mRNA expression of cells treated
with RNAi targeting luciferase, a gene that is not expressed in fly
cells, and thus serves to control for non-specific RNAi effects.
qRT-PCR of dPit mRNA was unaffected by RNA-mediated
knockdown of MFS10 and MFS13 and vice versa. To exclude off-
target effects of the dsRNA affecting phosphate-induced MAPK
independent of the transporters under investigation we further-
more showed that several independent dsRNAs targeting MFS10,
13 and Pit1 have similar effects.
Phosphate-uptake studies
Plasmids encoding full-length cDNAs of FBgn0010497,
FBgn0030452, and FBgn0260795 were obtained from the Drosophila
Genome Resource Center (DGRC, https://dgrc.cgb.indiana.edu/).
Flybase (http://flybase.org/) notes only one transcript and
protein for each transporter genes and nucleotide sequence
analysis was used to independently confirm presence of initiation
codon and poly-adenylation signal in the cDNAs obtained from
the DGRC prior to preparation of cRNA for expression in
Xenopus oocytes using the mMessage Machine T7 and polyA-
tailing kits (Ambion), and PCR-based templates generated using a
sense primer containing the T7 promotor sequence (for primer
sequences see Table S1). Full length of cRNA transcripts was
confirmed using denaturing gel electrophoresis, and thus it is
unlikely that non-functional splice variants or incomplete proteins
were expressed.
For phosphate-uptake experiments, Xenopus oocytes were
harvested from female frogs by C-section, de-folliculated and
injected with 50 ng capped and poly-adenylated RNA in 100 nl
per oocyte, prepared with the mMessage Machine kit (Ambion) as
previously described [43]. Following incubation in ND96+++
buffer (NaCl 0.192 M; KCl 4 mM; HEPES pH 7.4, 20 mM;
CaCl2 1.8 mM; MgCl2 1 mM; 16 penicillin/streptomycin) for
three days at 18 C to permit protein expression, phosphate uptake
was measured in ND100 (100 mM NaCl, 2 mM KCl, 1.8 mM
CaCl2, 1 mM MgCl2, 1 mM Pi, 10 mM Hepes-Tris (pH 7.4),
supplemented with [33P]-orthophosphoric acid (Perkin Elmer)
(final specific activity, 5–50 mCi/mmol) at room temperature for
60 min., followed by four washes in ND0+2 mM Pi, lysis and
detection of single-oocyte uptake using a scintillation counter. For
sodium-free conditions 100 mM choline-chloride was substituted
for 100 mM sodium-chloride to obtain ND0.
Fly culture and crosses
Standard fly culture was performed at 25uC on 17 g/l yeast,
9.8 g/l soy flour, 71 g/l corn meal, 5.6 g/l agar, 5.6 g/l malt,
75 ml/l corn syrup, 4 ml/l propionic acid and 250 mg/l tegosept
(Spectrum M1187). This medium was supplemented with 30 mM
sodium-phosphate (pH6.0), sodium-sulfate (pH 6.0), 10 mM
phosphonoformic acid (Sigma P6801), or 1% sevelamer (gift from
Dr. Yves Sabbagh, Genzyme, Inc.).
P-element insertions and deficiency mutants targeting the
genomic locus of MFS13 (FBgn0010497) were obtained from the
Bloomington Drosophila Stock Center (BDSC, http://flystocks.bio.
indiana.edu/), and the Exelexis collection (https://drosophila.
med.harvard.edu/): P{PZ}l(2)01810
01810/CyO; ry506 (Blooming-
ton stock 11076), y1 w67c23 P{wHy}l(2)01810
DG29108 (Blooming-
ton stock 20492), y1 w*; Mi{MIC}l(2)01810
MI00602, P{XP}l(2)
01810
d06403, PBac{RB}l(2)01810
e02547, w1118; Df(2L)BSC826/
SM6a (Bloominton stock 27900), w1118; Df(2L)BSC323/CyO
(Bloomington stock 24348) (for genomic location of these
insertions see Figure S1A and B).
While four P-element insertions were homozygous viable,
P{PZ}l(2)01810
01810 cn1 and the deficiencies were lethal. To
examine, whether lack of viability of these stocks is related to
homozygous loss of MFS13, we generated flies of the genotypes
P{PZ}l(2)01810
01810/Df(2L)BSC826 and P{PZ}l(2)01810
01810/
Df(2L)BSC323, which were viable. Loss of MFS13 in these
heterozygous flies was confirmed by quantitative RT-PCR. Briefly,
5 flies were collected for total RNA preparation using Trizol
reagent (Invitrogen). cDNA was synthesized using the Omniscript
cDNA reverse transcription kit (Qiagen). The levels of mRNA for
different genes were measured by using SYBR-GREEN Quanti-
Tect (Qiagen) on a StepOnePlus real time PCR system (Applied
Biosystems). For these experiments RpL32 (FBgn0002626) was
used for normalization, which, unlike actin5C, is not influenced by
culture temperature of the flies [44]. The primers used are listed in
Table S1.
Statistical analysis
Assay variability was generally less than 10% for Westernblot,
qPCR and phosphate uptake experiments. Means6SEM of at
least three independent experiments performed in duplicate are
shown.
MFS Transporters in Fly Phosphate Response
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Species Ensembl Gene ID Ensembl Transcript ID Ensembl Protein ID
MGH-
nomenclature
Associated
Gene Name
S.cerevisiae YML123C YML123C YML123C pho84
D.melanogaster FBgn0031307 FBtr0077958 FBpp0077623 MFS3 CG4726
D.melanogaster FBgn0030452 FBtr0073724 FBpp0073555 MFS10 CG4330
D.melanogaster FBgn0010497 FBtr0080292 FBpp0079876 MFS13 l(2)01810
D.melanogaster FBgn0010651 FBtr0086635 FBpp0085817 MFS14 l(2)08717
D.melanogaster FBgn0034392 FBtr0086636 FBpp0085818 MFS15 CG15094
D.melanogaster FBgn0034611 FBtr0071590 FBpp0071516 MFS16 CG10069
D.melanogaster FBgn0058263 FBtr0113848 FBpp0112571 MFS17 CG40263
D.melanogaster FBgn0058263 FBtr0113848 FBpp0112571 MFS17 CG40263
D.melanogaster FBgn0025684 FBtr0077456 FBpp0077146 MFS18 CG15438
D.melanogaster FBgn0039886 FBtr0085870 FBpp0085229 CG2003
D.melanogaster FBgn0039886 FBtr0085870 FBpp0085229 CG2003
D.melanogaster FBgn0031645 FBtr0077391 FBpp0077083 CG3036
D.melanogaster FBgn0031645 FBtr0077391 FBpp0077083 CG3036
D.melanogaster FBgn0038099 FBtr0300278 FBpp0289506 CG7091
D.melanogaster FBgn0016684 FBtr0087463 FBpp0086593 MFS2 NaPi-T
D.melanogaster FBgn0033234 FBtr0088849 FBpp0087925 MFS12 CG8791
D.melanogaster FBgn0034394 FBtr0086632 FBpp0085814 CG15096
D.melanogaster FBgn0042126 FBtr0289986 FBpp0288424 CG18788
D.melanogaster FBgn0024315 FBtr0087115 FBpp0086261 MFS8 Picot
D.melanogaster FBgn0033048 FBtr0086033 FBpp0085369 CG7881
D.melanogaster FBgn0028513 FBtr0080512 FBpp0080090 CG9254
D.melanogaster FBgn0029727 FBtr0070715 FBpp0070683 CG6978
D.melanogaster FBgn0031424 FBtr0077769 FBpp0077449 MFS11 VGlut
D.melanogaster FBgn0034490 FBtr0086320 FBpp0085628 CG9864
D.melanogaster FBgn0034782 FBtr0071892 FBpp0071803 CG12490
D.melanogaster FBgn0034783 FBtr0071893 FBpp0071804 CG9825
D.melanogaster FBgn0034784 FBtr0071895 FBpp0071806 CG9826
D.melanogaster FBgn0034785 FBtr0071896 FBpp0071807 CG3649
D.melanogaster FBgn0038799 FBtr0083888 FBpp0083296 MFS9 CG4288
D.melanogaster FBgn0050265 FBtr0071891 FBpp0071802 CG30265
D.melanogaster FBgn0050272 FBtr0071890 FBpp0071801 MFS1 CG30272
H.sapiens ENSG00000124568 ENST00000244527 ENSP00000244527 SLC17A1
H.sapiens ENSG00000112337 ENST00000377850 ENSP00000367081 SLC17A2
H.sapiens ENSG00000124564 ENST00000360657 ENSP00000353873 SLC17A3
H.sapiens ENSG00000146039 ENST00000377905 ENSP00000367137 SLC17A4
H.sapiens ENSG00000119899 ENST00000355773 ENSP00000348019 SLC17A5
H.sapiens ENSG00000091664 ENST00000263160 ENSP00000263160 SLC17A6
H.sapiens ENSG00000104888 ENST00000221485 ENSP00000221485 SLC17A7
H.sapiens ENSG00000179520 ENST00000323346 ENSP00000316909 SLC17A8
H.sapiens ENSG00000101194 ENST00000370351 ENSP00000359376 SLC17A9
H.sapiens ENSG00000160190 ENST00000352133 ENSP00000344648 SLC37A1
H.sapiens ENSG00000134955 ENST00000308074 ENSP00000311833 SLC37A2
H.sapiens ENSG00000157800 ENST00000326232 ENSP00000321498 SLC37A3
H.sapiens ENSG00000137700 ENST00000330775 ENSP00000339048 SLC37A4
Transporter protein IDs used for BLAST and Bayes phylogenetic analysis.
doi:10.1371/journal.pone.0031730.t001
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Phosphate activates MAPK in S2R+ cells in a time and
dose-dependent fashion
To establish an assay for phosphate sensing in Drosophila,w e
investigated whether, as observed in mammalian cells, phosphate
can activate MAPK in Drosophila cells. Drosophila S2R+ cells were
exposed to 10 mM sodium-phosphate buffer (pH7.4) and a
phospho-specific ERK antibody was used to detect MAPK
response (Fig. 1A). Phosphate activates MAPK rapidly within
3 min. and desensitizes over the course of 15 min (Fig. 1B).
Activation is dose-dependent, and reaches a maximum at 10 mM
(Fig. 1C). Activation of MAPK is not seen with an iso-osmolar
stimulus of 10 mM sodium-sulfate (Fig. 1B). The time course of
activation by phosphate is similar to activation of MAPK by
25 ug/ml insulin, but when compared to phosphate, activation of
MAPK by insulin appears to be more sustained and returns back
to baseline after 30–60 min. (data not shown). Long-term exposure
to 10 mM phosphate or insulin over 24 hrs does not lead to
significant activation of MAPK above baseline (data not shown).
Similar time-dependent activation of MAPK is seen in a second
Drosophila hemocyte-like cell line, Kc167 (Fig. 1D). Different,
however, from S2R+ cells, activation of MAPK is followed by
suppression below baseline after 10 and 15 min, with return to
baseline after 30 min.
Addition of phosphonoformic acid (PFA) blocks activation of
MAPK by phosphate in mammalian cell lines [29,30], indicating
that binding or cellular uptake of phosphate is required for the
activation of MAPK. Similarly, exposure to PFA for 60 min. prior
to stimulation with 10 mM phosphate blocked activation of
MAPK in S2R+ cells, although higher doses were required
(30 mM) when compared to what is effective in mammalian cell
lines (5–10 mM, [29,30])(Fig. 1E). Importantly, PFA blocks
phosphate- but not insulin-induced MAPK in S2R+ cells,
indicating that phosphate activates MAPK using a different
signaling pathway. Phosphate, furthermore, is unable to induce
phosphorylation of AKT in S2R+ cells (data not shown).
Drosophila cell lines express orthologs of mammalian
type I and type III phosphate transporters
To characterize the Drosophila phosphate transporters involved
in MAPK activation, we determined which orthologs of
mammalian type I and type III phosphate transporters are
expressed in Drosophila S2R+ cells. The Drosophila genome contains
orthologs of mammalian type I and type III phosphate
transporters, but lacks orthologs of the mammalian type II
transporters [22]. While there is only one Drosophila type III
transporter ortholog, dPit (FBgn0260795), type I phosphate
transporters belong to the MFS and share the protein domain
PF07690, which is present in 77 yeast proteins, 219 Drosophila
proteins, and 229 human proteins. We used BLAST followed by
Bayes phylogenetic analysis to identify 29 fly orthologs that are
most closely related to yeast Pho84 and human SLC17A1–9 (Fig. 2,
Table 1, Tables S2.1–3).
Eight of these transporters are expressed in S2R+ cells when
checked against publically available cell-specific RNA expression
profiles using high-density genome tiling microarrays from
ModENCODE [45], and Affymetrix and Flychip Drosophila
expression array data from FLIGHT [46] (see Table S3). The
expression profile of these eight MFS transporters was similar in
17 Drosophila cell lines including S2R+ and Kc167 cells, consistent
with a universal role in phosphate-sensing (see Table S4).
Expression of the eight transporters was confirmed using qRT-
PCR of total RNA extracted from S2R+ cells (Fig. 3A). Relative
expression levels were tested with several independent primer sets
for qRT-PCR and found to be within one order of magnitude of
the expression of Drosophila actin 5 C. Modest up-regulation of the
expression of some transporters was observed, when S2R+ cells
were cultured for three days in the absence of phosphate (Fig. 3A).
The sequence alignment of the eight expressed fly transporters
shows 7.6–12.9% amino acid identity to pho84, compared to 12.2–
45.2% amino acid identity among each other (Fig. S2A), with
higher degree identity seen in hydrophobic, predicted membrane-
spanning regions of these transporters (18.9–27.5% to pho84 and
19.1–51.1% among the fly transporters (Fig. S2B and S2C).
RNAi knockdown of MSF transporters blocks phosphate-
but not insulin-induced MAPK in S2R+ cells
siRNA-mediated knockdown of the Pit1 sodium-phosphate co-
transporter blocks activation of MAPK by phosphate in human
embryonic kidney (HEK293) cells [27] indicating that this type III
sodium-phosphate co-transporter [19] is required for the activa-
tion of MAPK in this cell line. However, RNAi knockdown of the
dPit only reduced phosphate-induced MAPK by 20% in S2R+
cells (Fig. 3B). Findings were similar with three independent
dsRNAs and quantitative RT-PCR confirmed that the Pit1
mRNA level was reduced 100-fold when compared to baseline,
i.e. cells transfected with dsRNA targeting luciferase, a gene not
expressed in S2R+ cells and thus serving as a control for non-
specific RNAi effects (Fig. 3C).
Individual knockdown of two of the eight expressed MFS
transporters, MFS10 and MFS13 (encoded by FBgn0030452 and
FBgn0010497, respectively) resulted in 40% reduction of phos-
phate-induced MAPK, which exceeds the effect seen by knock-
down of dPit (Fig. 3B). Knockdown of these MFS transporters was
specific for phosphate, since insulin continued to be able to
stimulate MAPK. These results were reproducible by two
independent sets of dsRNAs targeting MFS10 and MFS13).
Furthermore, knockdown of all three transporters was additive and
resulted in 60% reduction of phosphate-induced MAPK. Con-
versely, RNAi targeting the insulin receptor blocked insulin-
induced MAPK, but not phosphate-induced MAPK. Finally,
RNAi-knockdown of the upstream kinase, MEK, blocked
stimulation of MAPK in response to both stimuli, indicating that
MAPK phosphorylation by phosphate is mediated by MEK.
Interestingly, one transporter (encoded by FBgn0031307)
appears to be a specific negative regulator of phosphate-induced
MAPK. Further, while insulin-induced MAPK was unaffected,
two transporters (encoded by FBgn0010651 and FBgn0034392)
were positive regulators of both phosphate- and insulin-induced
MAPK, while knockdown of three transporters (encoded by
FBgn0034611, FBgn0058263, and FBgn0025684) had no significant
effect on phosphate-induced MAPK.
MFS13 (FBgn0010497) mediates Na-dependent
phosphate-uptake when expressed in Xenopus oocytes
To test whether MFS10 and MFS13 facilitate cellular
phosphate uptake, we injected capped and poly-adenylated sense
RNA encoding these transporters into Xenopus oocytes. Following
injection of 50 ng/oocyte and culture at 18 C for three days to
allow for expression of the transporter protein in the oocyte plasma
membranes, we performed a radioactive-phosphate uptake
experiment in the absence or presence of sodium and PFA at
pH5.5, 7.4, and 8.5.
MFS13 showed significant uptake of phosphate, while no
significant uptake was seen when expressing MFS10. Uptake
mediated by MFS13 was similar in magnitude to that seen with
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human SLC34A3 (NaPi-IIc)(data not shown). Radioactive phos-
phate uptake was dependent on sodium and blocked by PFA or
low pH, while transport was maximal at physiological pH 7.4 and
at pH 8.5 (Fig. 4). Altogether, these results indicate that MSF13,
but not MSF10, mediates uptake of [
33P]-orthophosphate in a
sodium-dependent fashion.
Phosphonoformic acid and sevelamer impair larval
development in fly
A search in FlyAtlas [47] reveals that MFS10 (FBgn0030452)
mRNA is expressed highest in the male accessory gland, two-fold
enriched in brain and four-fold enriched in the Malpighian tubule,
the renal tubule equivalent in fly, when compared to whole fly
expression. MFS13 (FBgn0010497) mRNA is expressed highest in
the crop, midgut, Malpighian tubule, and hindgut, where it is
three-fold enriched when compared to whole fly (Fig. S3). No
entry is found for dPit.
To explore the role of phosphate during larval development of
Drosophila we cultured wild-type flies in 0.5% sevelamer to inhibit
absorption of dietary phosphate [48] and 1 mM PFA to block
phosphate transport into cells [49]. This treatment delayed
embryonic and larval development (Fig. S4A and B). The effect
of sevelamer and PFA was reversed by addition of 30 mM sodium
phosphate.
To further evaluate the role of MFS13 in vivo, we obtained a P-
element insertion in MFS13 (P{PZ}l(2)01810
01810) that was viable
over two deficiencies of the region (Df(2L)BSC826, Df(2L)
BSC323). qPCR analysis of adult flies of the genotype P{PZ}l(2)
01810
01810/Df(2L)BSC826 or P{PZ}l(2)01810
01810/Df(2L)BSC323
revealed that MFS3 expression is most likely completely absent,
suggesting that MSF13 mediates phosphate transport together
with other transporter(s) (Fig. S1C).
Discussion
In this study, we show that activation of MAPK is part of the
down-stream events stimulated when two Drosophila hemocyte-like
cell lines, S2R+ and Kc167, are exposed to phosphate. Just like in
mammalian cell lines, we furthermore found that PFA blocks
phosphate induced MAPK in S2R+ Drosophila cells. Activation of
MAPK by phosphate, which thus far has only been shown in
Figure 1. Western blot analysis of phosphate-induced MAPK in S2R+ and Kc167 cells. A: Dose response and time course of phosphate-
activated MAPK in S2R+ cells. B: Dose response of phosphate-activated MAPK in S2R+ cells. C: Time course of phosphate-activated MAPK in S2R+
cells. D: Time course of phosphate-activated MAPK in Kc167 cells. E: Effect of PFA on activation of MAPK in S2R+ cells Shown are one representative
Western blot autoradiogram (A), or pooled densitometic data of at least three independent Western blot experiments (B–E). Abbreviations:
Pi=inorganic phosphate, Ins=human insulin, Ly=Ly294002 (PI3K-inhibitor, 50 uM), PFA=phosphonoformic acid (30 mM, unless otherwise noted),
S10=sodium sulfate (10 mM), P10=sodium phosphate (10 mM).
doi:10.1371/journal.pone.0031730.g001
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PLoS ONE | www.plosone.org 6 February 2012 | Volume 7 | Issue 2 | e31730Figure 2. Blast and Bayes analysis of MFS transporters. Heatmap of pairwise BLAST bit scores for all known yeast, Drosophila and human
proteins containing the MFS protein domain PF07690 [38] (left panel) sorted by a hierarchical clustering (middle panel). Bayesian phylogenetic
reconstruction (dendogram) was used to identify 29 fly orthologs that are most closely related to yeast Pho84 (YML123C) and human SLC17A1–9.
Posterior probabilities are indicated above each branch. Fly transporters found to be expressed in S2R+ cells are shown in bold/italic script.
doi:10.1371/journal.pone.0031730.g002
Figure 3. Effect of RNAi knockdown of MFS transporters and dPit on MAPK. A: mRNA expression of MFS and Pit transporters in S2R+ cells.
Data of three replicate experiments are shown as mean6SEM expression relative to actin 5 C. B: Effect of RNAi knockdown of MFS transporters and
dPit on MAPK. Data of three replicate experiments are shown as mean6SEM relative to cells transfected with dsRNA targeting lucifierase (luc). C: RNAi
knockdown efficiency. To calculate efficiency of knockdown, parallel wells prepared for pERK1/2 Western analysis above (Fig. 2B) were used for total
RNA extraction and quantitative RT-PCR. Shown are mean6SEM of three replicate experiments after expression was corrected for actin 5 C mRNA.
Cells treated with dsRNA targeting luciferase are set 100% for each specific primer pair.
doi:10.1371/journal.pone.0031730.g003
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to be evolutionarily conserved.
Activation of the MAPK pathway by phosphate in metazoan
species is likely relevant for cellular functions as has been shown
for the regulation of RANK/RANK-L signaling [50], mRNA
expression of bone matrix proteins osteopontin [24], and matrix
gla protein [51] or down-regulation of type III transporters Pit1
and Pit2 [52], all of which are blocked by UO126, an inhibitor of
the upstream MAPK-kinase MEK. Yet, it is poorly understood,
whether phosphate needs to enter metazoan cells to stimulate
intracellular signaling events as suggested by the inhibitory action
of PFA, or whether it binds and activates a cell surface receptor.
In yeast the major facilitator superfamily transporters Pho84 and
the type III transporter Pho 89 have been implicated in phosphate-
sensing in yeast [16]. Recent evidence suggests that the
mammalian ortholog of Pho89, Pit1, mediates cellular effects of
phosphate, however, we found in S2R+ cells that knockdown of
the fly ortholog dPit only reduced activation of MAPK by
phosphate by 20% when compared to control, while it reduced
dPit mRNA by more than 90%. Since orthologs of the type II co-
transporters are absent from the Drosophila genome, we therefore
postulated that a type I co-transporter ortholog related to Pho84
may be involved in phosphate sensing in Drosophila S2R+ cells.
Despite sequence divergence and size of this transporter family we
were able to identify eight fly Pho84 candidates based on sequence
homology to the human MFS transporters SLC17A1–9, and
expression in our cell line. These eight transporters are highly
expressed in a number of other fly cell lines as shown in Table S4,
supportive of their universal role for phosphate-sensing. Evalua-
tion of these eight MFS members using phosphate-induced MAPK
as readout provides evidence that four Drosophila type I (MFS)
transporters are positive regulators, while one transporter is a
negative regulator of phosphate-induced MAPK. Three of these
five transporters specifically affect phosphate, while insulin-
induced MAPK was unaffected. We decided to further investigate
the two positive and specific regulators MFS10 and MFS13
(encoded by FBgn0030452 and FBgn0010497), which are required
for the activation of MAPK by phosphate in S2R+ cells. Further
evaluation after expression in Xenopus oocytes indicates that one of
these two transporters (MFS13, encoded by FBgn0010497) shows
significant phosphate conductance, which is comparable in
magnitude to that seen with dPit. Consistent with the mechanism
of transport known for human SLC17A1–9, this phosphate
conductance is sodium-dependent and inhibited by PFA or low
pH. Our findings therefore provide first evidence for the presence
of multiple Pho84 orthologs in a multicellular organism, which
along with the Pho89 ortholog dPit are involved in phosphate-
sensing. The sequence alignment highlights conserved domains
and residues which may be involved in these functions (Fig. S2C).
Since 5 mM PFA is sufficient to inhibit the MFS13 transporter
after expression in X. oocytes, lower potency of PFA on MFS10,
dPit or possibly other transporters may explain the high
concentration of 30 mM PFA is needed to block phosphate
induced MAPK in S2R+ cells.
Loss of Pho84 reduces proliferation and survival in yeast, which
can be rescued by over-expressing the related phosphate
transporter Pho89 [16], suggesting that members of different
superfamilies permit cellular uptake of phosphate in yeast that
then is sensed intracellularly. However, the fact that overexpres-
sion of a phosphate-transport deficient Pho84 variant can rescue
regulation of the extracellular alkaline phosphatase Pho5 by
phosphate in Pho84 deficient strains, while overexpression of Pho89
is ineffective, suggests, that binding of extracellular phosphate
alone may be sufficient, at least for some down-stream effects of
phosphate in yeast [16]. Since multiple transporter are involved in
S2R+, our findings support the possibility that cellular uptake of
phosphate is required, and that also in metazoan cells intracellular
phosphate is what is sensed and what leads to activation of MAPK.
This study has several limitations that require future investiga-
tion: only 29 out of 219 known Drosophila pho84 orthologs were
examined and it is possible that other orthologs are expressed and
involved in phosphate-induced MAPK in S2R+ cells. Phosphate
transport data shown here are qualitative in nature and future
experiments have to include quantification of surface expression of
the fly transporters. Since transport for phosphate by MFS13 and
dPit was in our hands less efficient when compared to the human
type II sodium-phosphate co-transporter NaPi-IIc (data not
shown), and we were unable to show phosphate-conductance for
the second type I transporter MFS10 (encoded by FBgn0030452)i t
is possible that extracellular binding of phosphate to these
transporters leads to activation of intracellular events independent
of phosphate-uptake. Based on studies in mammalian cells, it is
possible, that Pit1 is the sole functional paralog of yeast Pho84 and
Pho89 in higher species [17,19]. Indeed, targeted deletion,
hypomorphic and overexpression mutants of Pit1 support a
fundamental role of this transporter in liver growth and phosphate
homeostasis of mice [32,33,34]. However, additional mechanisms
for phosphate-sensing possibly involving Pho84 orthologs may exist
since Pit1 null mice exhibit normal embryonic development and
morphogenesis. Consistent with an important role for phosphate
in metabolism and endocrine regulation we found that PFA and
sevelamer impair larval development of Drosophila. However, just
like in mice we also found that deletion of MFS13 is compatible
with larval development and metamorphosis of flies indicating that
loss of a single transporter can be compensated by others in vivo.
In conclusion, our findings suggest that activation of MAPK by
phosphate is evolutionarily conserved from fly to man. MFS
Figure 4. Phosphate transport after expression of MFS and dPit
transporters in X. oocytes. Phosphate uptake of Xenopus oocytes
injected with capped RNA encoding MFS10 (FBgn0030452), MFS13
(FBgn0010497), and dPit (FBgn0260795), was measured in ND100+
33P,
or ND0+
33P, in the presence or absence of 5 mM PFA at pH7.4 or at
pH5.5 or 8.5 where indicated.
33P-uptake is expressed in multiples over
basal seen with non-injected oocytes as mean6SEM from at least three
different batches of oocytes (n=10/bath).
doi:10.1371/journal.pone.0031730.g004
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along with dPit, which may be relevant for higher species and
humans. Further studies are required to better understand the role
of these transporters in Drosophila phosphate-homeostasis.
Supporting Information
Figure S1 P-element and deficiency stocks for MFS13
(l(2)01810, FBgn0010497). The insertion sites of the P-elements
obtained from flybase (www.flybase.org) is shown in A, the
location of available chromosome 2 deficiency mutants surround-
ing the genetic locus and including FBgn0010497 is shown in B.
qRT-PCR to confirm complete loss of MFS13 transcripts in
P{PZ}l(2)01810
01810/Df(2L)BSC826 (11076/27900) or P{PZ}l(2)
01810
01810/Df(2L)BSC323 (11076/24348) adult flies when com-
pared to heterozygous stocks and wild-type flies (CTRL) (C).
(TIF)
Figure S2 Sequence comparison between ph84 and MFS
transporters expressed in S2R+ cells. A: Global alignment.
Amino acid sequence identity in % between the sequence shown
in column and row (alignment length in brackets). B: Local
alignment. Amino acid sequence identity in % between sequence
shown in column and row (alignment length in brackets). C:
Clustal W alignment of fly transporters expressed in S2R+ cells
along with Pho84 using Jalview (http://www.jalview.org/download.
html).
(PDF)
Figure S3 FlyAtlas tissue distribution of MFS10
(FBgn0030452) and MFS13 (FBgn0010497). Using FlyAtlas
[47](http://flyatlas.org/) mRNA expression of MFS10, and
MFS13 (encoded by FBgn0030452, FBgn0010497, respectively) is
shown for various larval and adult fly tissues.
(TIF)
Figure S4 Phosphonoformic acid and sevelamer impair
larval development. Yellow white flies were cultured on
standard medium at 25uC. This medium was supplemented with
30 mM sodium-phosphate (pH6.0)(P30), 1 mM phosphonoformic
acid (PFA), or 0.5% sevelamer (Sev) or in combinations thereof.
Number of larvae emerged from the medium over time are shown.
(TIF)
Table S1 Primer sequences used for dsRNA synthesis,
cRNA synthesis and qRT-PCR. Primer sequences are
displayed 59 to 39 and include the T7-RNA-polymerase promotor
when used to generate PCR templates for dsRNA or cRNA
sythesis.
(XLS)
Table S2 Tables of all blast hits S. cerevisiae vs. D.
melanogaster (S2.1), D. melanogaster vs. D. melanoga-
ster (S2.2), D. melanogaster vs. human (S2.3) with the
following format. 1. Query ID (Ensembl). 2. Subject ID
(Ensembl). 3. % identity between query and subject, 4. alignment
length between query and subject, 5. mismatches between query
and subject, 6. gap openings between query and subject, 7. query
start, 8. query end, 9. subject start, 10. subject end, 11. e-value, 12.
bit score. 13. query family ID. 14. subject family ID.
(XLS)
Table S3 MFS expression in S2R+ cells. Cell-specific RNA
expression profiling for S2R+ cells using high-density genome
tiling microarrays (next generation RNAseq technology) was
obtained from ModENCODE [45], and using Affymetrix Flychip
Drosophila expression array technology was obtained from
FLIGHT [46]. Expression cut-off’s are given in brackets and
expressed genes are high-lighted in green.
(XLS)
Table S4 Expression data for Drosophila MFS trans-
porters in S2R+ cells. Cell-specific RNA expression profiling of
17 Drosophila cell lines using high-density genome tiling micro-
arrays (next generation RNAseq technology) was obtained from
ModENCODE [45], and using Affymetrix Flychip Drosophila
expression array technology was obtained from FLIGHT [46].
Expressed genes are highlighted in green (or blue for modest
expression).
(XLS)
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